Is vitamin D associated with severity of Parkinson's disease?

被引：0
|
作者：
Matutinovic, M. Saric [1 ]
Terzic, D. [2 ]
Dzoljic, E. [3 ,4 ]
Kostic, V. [3 ,4 ]
Ignjatovic, S. [1 ,2 ]
机构：
[1] Univ Belgrade, Fac Pharm, Belgrade, Serbia
[2] Clin Ctr Serbia, Inst Med Biochem, Belgrade, Serbia
[3] Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia
[4] Univ Belgrade, Fac Med, Belgrade, Serbia
来源：
CLINICA CHIMICA ACTA | 2019年 / 493卷
关键词：
D O I：
10.1016/j.cca.2019.03.1293
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
W373
引用
收藏
页码：S618 / S618
页数：1
相关论文
共 50 条
  • [21] Vitamin D and clinical phenotypes of Parkinson's disease
    Jamal, F.
    Jackson, G.
    Moore, S.
    Sarwar, A.
    MOVEMENT DISORDERS, 2017, 32
  • [22] Vitamin D Assessment in Veterans with Parkinson's Disease
    Jamal, Fariha
    Jackson, George
    Moore, Suzanne
    Sarwar, Aliya
    NEUROLOGY, 2019, 92 (15)
  • [23] Association of vitamin D deficiency in Parkinson's disease
    Mujtaba, A.
    Alshamrani, A.
    Marar, S.
    Alayan, T.
    Bajwa, J.
    MOVEMENT DISORDERS, 2017, 32
  • [24] Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
    Omer, Nurit
    Giladi, Nir
    Gurevich, Tanya
    Bar-Shira, Anat
    Gana-Weisz, Mali
    Glinka, Tal
    Goldstein, Orly
    Kestenbaum, Meir
    Cedarbaum, Jesse M.
    Mabrouk, Omar S.
    Fraser, Kyle B.
    Shirvan, Julia C.
    Orr-Urtreger, Avi
    Mirelman, Anat
    Thaler, Avner
    MOVEMENT DISORDERS, 2022, 37 (01) : 190 - 195
  • [25] The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson’s disease
    Lingling Lv
    Xuling Tan
    Xinke Peng
    Rongrong Bai
    Qile Xiao
    Ting Zou
    Jieqiong Tan
    Hainan Zhang
    Chunyu Wang
    Translational Neurodegeneration, 9
  • [26] Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity
    Omer, Nurit
    Giladi, Nir
    Gurevich, Tanya
    Bar-Shira, Anat
    Gana-Weisz, Mali
    Glinka, Tal
    Goldstein, Orly
    Kestenbaum, Meir
    Cedarbaum, Jesse M.
    Mabrouk, Omar S.
    Fraser, Kyle B.
    Shirvan, Julia C.
    Orr-Urtreger, Avi
    Mirelman, Anat
    Thaler, Avner
    MOVEMENT DISORDERS, 2022, 37 (03) : 651 - 652
  • [27] The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson's disease
    Lv, Lingling
    Tan, Xuling
    Peng, Xinke
    Bai, Rongrong
    Xiao, Qile
    Zou, Ting
    Tan, Jieqiong
    Zhang, Hainan
    Wang, Chunyu
    TRANSLATIONAL NEURODEGENERATION, 2020, 9 (01)
  • [28] 25-Hydroxyvitamin D and Severity of Parkinson's Disease
    Chitsaz, Ahmad
    Maracy, Mohammad
    Basiri, Keivan
    Boroujeni, Maryam Izadi
    Tanhaei, Amir Pouya
    Rahimi, Marzieh
    Meamar, Rokhsareh
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [29] The Role of Vitamin D in Disease Progression in Early Parkinson's Disease
    Sleeman, Isobel
    Aspray, Terry
    Lawson, Rachael
    Coleman, Shirley
    Duncan, Gordon
    Khoo, Tien K.
    Schoenmakers, Inez
    Rochester, Lynn
    Burn, David
    Yarnall, Alison
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (04) : 669 - 675
  • [30] Vitamin D in the Parkinson's associated risk (PARS) study
    Fullard, M.
    Xie, S.
    Marek, K.
    Stern, M.
    Jennings, D.
    Siderowf, A.
    Chen-Plotkin, A.
    MOVEMENT DISORDERS, 2017, 32
12345